AstraZeneca could become the first company to bring an oral selective oestrogen receptor degrader (SERD) drug to market as a first-line treatment for breast cancer after camizestrant hit the mark in a ...
Israel and several Persian Gulf nations reported a new influx of drone and missile launches toward them early Thursday ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results